Início › Câncer (todos os tipos) › Minnesota › Rochester
Ensaios clínicos de Câncer (todos os tipos) em Rochester, MN
30 estudos para Câncer (todos os tipos) estão buscando participantes em locais em Rochester e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecrutandoFase 3
- Investigative Site, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- Mayo Clinic Rochester, Rochester
A Study of JNJ-1761981 in Participants With Solid Tumors
RecrutandoFase 1
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecrutandoFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecrutandoFase 3
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RecrutandoFase 2/3
- Mayo Clinic, Rochester
Statins to Prevent Cancer Associated Blood Clots
RecrutandoFase 4
- Mayo Clinic, Rochester
Biomarkers of Resiliency In Childhood Cancer Surgery
RecrutandoEstudo observacional
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RecrutandoFase 1/2
- Mayo Clinic Rochester, Rochester
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RecrutandoEstudo observacional
- Mayo Clinic Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Project: Every Child for Younger Patients With Cancer
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RecrutandoFase 3
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Mayo Clinic, Rochester
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Mayo Clinic in Rochester, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecrutandoFase 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecrutandoFase 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecrutandoFase 1
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Mayo Clinic Rochester, Rochester
Patient Derived Preclinical Models
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Recrutando
- Mayo Clinic, Rochester
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Mayo Clinic Rochester, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecrutandoFase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecrutandoFase 1/2
- Mayo Clinic, Rochester
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
RecrutandoEstudo observacional
- Mayo Clinic in Rochester, Rochester
Multi-Cancer Detection Observational Cohort Study
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Mayo Clinic in Rochester, Rochester
Suprachoroidal Administration in Subjects With Metastases to the Choroid
RecrutandoFase 2
- Mayo Clinic, Rochester
Primary Tumor Research and Outcomes Network
RecrutandoEstudo observacional
- Mayo Clinic, Rochester
Testicular Tissue Cryopreservation in Children
Recrutando
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Mayo Clinic, Rochester
Ensaios de Câncer (todos os tipos) em outras cidades
- Houston, TX121 estudos
- New York City, NY110 estudos
- Boston, MA86 estudos
- Los Angeles, CA73 estudos
- Nashville, TN65 estudos
- Philadelphia, PA59 estudos
- Durham, NC58 estudos
- Washington, DC58 estudos
- Chicago, IL51 estudos
- Seattle, WA49 estudos
- Atlanta, GA49 estudos
- Arlington, VA48 estudos
Outros estudos em Rochester
- Câncer de Mama42 estudos
- Câncer de Pulmão de Não Pequenas Células37 estudos
- Câncer Metastático31 estudos
- Câncer Colorretal29 estudos
- Câncer de Ovário29 estudos
- Mieloma Múltiplo24 estudos
- Câncer de Próstata22 estudos
- Insuficiência Cardíaca22 estudos
- Câncer de Pâncreas22 estudos
- Câncer de Pulmão20 estudos
- Câncer Endometrial20 estudos
- Leucemia Linfocítica Crônica19 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.